Table 2 Participant characteristics
Characteristic | N (%) | Characteristic | N (%) |
|---|---|---|---|
Age (years) | CSER investigator | 20 (43%) | |
?20–29 | 4 (7%) | ||
?30–39 | 18 (33%) | CSER study affiliation a | |
?40–49 | 10 (19%) | BASIC3 | 7 (13%) |
?50–59 | 14 (26%) | ClinSeq | 6 (11%) |
?60–69 | 7 (13%) | HudsonAlpha | 4 (7%) |
?70+ | 1 (2%) | MedSeq | 7 (13%) |
MI-ONCOSEQ | 6 (11%) | ||
Gender | NCGENES | 8 (15%) | |
?Male | 25 (46%) | NEXT Medicine | 4 (7%) |
?Female | 29 (54%) | NextGen | 3 (6%) |
PediSeq | 6 (11%) | ||
Race | Other | 4 (7%) | |
?White non-Hispanic | 43 (80%) | ||
?Asian | 7 (13%) | Rating of genetics training | |
?Other | 4 (7%) | Not at all sufficient | 2 (4%) |
Somewhat insufficient | 5 (9%) | ||
Neutral | 3 (6%) | ||
Specialty a | Somewhat sufficient | 15 (28%) | |
?Genetic counseling | 21 (39%) | More than sufficient | 29 (54%) |
?Medical genetics | 17 (31%) | ||
?Pediatrics | 14 (26%) | Tests ordered/disclosed within 12 months | |
?Oncology | 11 (20%) | Genetic test | 50 (93%) |
?Internal medicine | 6 (11%) | Genomic sequencing | 51 (94%) |
?Cardiology | 4 (7%) | ||
?Otherb | 9 (17%) | Practice setting a | |
Hospital | 41 (76%) | ||
Clinic | 16 (30%) | ||
Other | 12 (22%) |
